Resources from the same session
Modified FOLFOXIRI plus panitumumab (mFOLFOXIRI/PAN) versus mFOLFOX6/PAN as initial treatment of unresectable RAS/BRAF wild-type metastatic colorectal cancer (mCRC) patients: results of the phase III randomized TRIPLETE study by GONO
Presenter: Daniele Rossini, Italy
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Algorithms in First-Line and Second-Line Metastatic Disease
Presenter: Dirk Arnold, Germany
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Evidence of therapeutic effectiveness of III line cetuximab rechallenge in appropriately selected patients: finding from long-term follow-up of CRICKET and CAVE trials
Presenter: Erika Martinelli, Italy
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Treatment Algorithms After Second-Line Metastatic Disease
Presenter: Fortunato Ciardiello, Italy
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Evaluating age as a factor for survival and quality of life in patients with BRAF V600E-mutant metastatic colorectal cancer treated with encorafenib + cetuximab ± binimetinib: subanalysis of BEACON CRC
Presenter: Kimmie Ng, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Clinical efficacy and single cell analysis of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients
Presenter: Ryan Corcoran, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Association of MSS/MSI-RNF43 molecular subtypes and clinical outcome of metastatic BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR ± combinatorial therapies
Presenter: Rodrigo Toledo, Spain
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
Talks on Checkpoint Inhibitors in MSI-H Colorectal Cancer
Presenter: Thierry André, France
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
How to Make MSS Tumors More Sensitive for Immunotherapy
Presenter: Ryan Corcoran, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides
BRAF Mutant Tumors: Strategy and New Data
Presenter: Scott Kopetz, United States
Session: Session XXII: Colorectal Cancer: Metastatic Disease
Resources:
Slides